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ABSTRACT

Background
This article accepts the premise of stakeholder theory,
which asserts that corporations, like other human-run entities, have obligations to all parties affected by their actions. As such, corporations should be given suitable credit
for projects that add value for these stakeholders, as well
as held accountable for any damage done. To provide
this credit and accountability, measurement is necessary.
The methodology of measurement for corporate social
value creation is in its infancy. Models are incomplete,
measures are not validated, and methods used to esti-

mate net value accumulated from different domains need
improvement.

Purpose
This article builds on one model of global value added
(GVA), examining what methods are necessary to identify relevant domains, provide valid measures, and combine findings for the wide range of domains encompassed
by a corporations’ projects.
Significance
Once this methodology is successfully established,
creation of valid measurement scales will warrant emer-
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gence of a subdiscipline in business and economics. To
use these scales suitably will be a challenge on yet another level, but the potential for an industry index based
not on economic but global measures will exist, allowing
for fair and transparent accountability of commercial sector activities to other sectors of society. This has particular implications for the health sector, with its complex web
of numerous stakeholders. The measurement modality
presented here provides the possibility of evaluating all
these health sector entities’ contributions to society.
INTRODUCTION
Stakeholder theory has demanding implications for corporations. Contrary to the view
of neoclassical economists that the main goal
of corporations should be to maximize profit
to shareholders,1 the corporate social responsibility movement demands that corporations
recognize other obligations to society. Borrowing from stakeholder theory,2, 3 this movement
focuses on a company’s duty to stakeholders
other than stockholders (who are also stakeholders). These stakeholders can be a corporations’ employees demanding better treatment, environmental groups demanding environmental sensitivity, or a country’s government in which a multinational corporation is
operating requesting assistance in preventing
the spread of HIV/AIDS among the populace.
Stakeholder advocates have defined broad
domains of corporate social responsibility,
leading to a potentially complex web of commitments for corporations.
In the healthcare sector, this web of commitments to patients, payers, healthcare delivery organizations, communities, and others is particularly complex. Developing a coherent measure of performance that is relevant
to them could considerably advance assessment of the contributions of businesses in the
health sector to meeting society’s needs. However, the measurement modality presented
here would also be applicable to the other
entities that comprise the health sector, including the aforementioned stakeholders.
Thus, there is the potential for a comprehen-
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sive evaluation of the value added or destroyed by different groups in the health sector, not just patients or payers, as has traditionally been the case.
Several researchers have created conceptual models that attempt to give a framework
for understanding corporate social responsibility, such as Wood’s4, 5 Corporate Social Performance (CSP) model and Swanson’s6 reorientation of Wood’s model. Wood’s model is
important because it shifts the focus onto corporate social responsibility outcomes as they
are achieved through management organization and processes. Swanson’s model adds to
our understanding of CSP by describing the
value orientations that corporate decision
makers use, as well as more micro-level decision-making processes. However, neither
model presents a coherent measurement modality for CSP, although Wood in particular
urges the creation of methodologies to evaluate the social impacts of business activities.
At present, the measurement research in
the area of corporate social performance still
has major problems that need to be remedied.
Non-validated measures and inadequate
methods for compiling measures across different domains are two primary issues. Perhaps more problematic is the fact that the research also tends to focus on the wrong research question. Most measurement research
has not asked “How do you measure CSP?”
but rather “Do CSP projects contribute to Corporate Financial Performance (CFP)?” This
seems to be a premature question to ask when
a well-theorized measurement methodology
has not yet been developed.
Much effort has gone into the construction of various CSP indices, such as the Domini 400 Social Index (DSI 400), derived from
the Kinder Lydenberg Domini (KLD) rating
system, in which each company on the Standard & Poors (S&P) 500 is rated on 11 dimensions of Corporate Social Responsibility
(CSR).7 While these are positive endeavors,
they need to be conducted with valid measurement methodologies. These types of mea-
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surements are often based on the subjective
ratings of evaluators and may measure
reputational aspects of CSR rather than the
actual social impacts of CSR activities. In addition, they rarely use validated measures, and
their methods for compiling measures from a
variety of dimensions are simplistic or absent.
Perhaps not surprisingly, the results of 122
studies over nearly a 30-year period, starting
in 1972,8 have been decidedly mixed. Some
have found a negative relationship between
CSP and CFP,9 some a positive relationship,10,
11
and some no relationship at all.12, 13, 14 At this
point, it remains impossible to tell whether
these mixed results reflect reality or the suboptimal methods that cloud analysis.15
It is perhaps laudable that many companies now include CSR information in their
annual reports; however, these reports are
unable to rely on readily available or accepted
measurement methods. In keeping with the
saying, “If you can’t measure it, you can’t improve it,” in this article we propose a rigorous methodology for accurately measuring
CSP. We seek to return to the fundamental research question, “How do you measure CSP?”
which we believe has not been satisfactorily
answered thus far.
In this work, part of a series that focuses
on health-related CSR projects for illustrations
of the theoretical framework, we borrow from
Hughes and colleagues’16 proposal laying out
a three-sector model of society, and seek a unifying metric designed to measure CSP for a
given CSR project. In the view of Hughes and
his colleagues, the most successful CSR
projects will be at the intersection of the three
relevant societal sectors: commercial, socialprofessional, and political. The commercial
sector includes all for-profit business, and the
social-professional sector is comprised of the
traditional professions such as law and medicine as well as nongovernmental organizations
(NGOs) and nonprofits. The political sector
includes organizations that represent or govern members of a social group. The unifying
metric that Hughes and colleagues propose is
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Global Value Added (GVA), and they distinguish at least two components: Economic
Value Added (EVA) and Social Value Added
(SVA).
Triple bottom line theorists would contend
that there are three relevant components for
Global Value Added—economic/financial, social, and environmental.17 We subsume social
and environmental concerns under SVA, although we acknowledge that there are important theoretical gains to be made from a
sustainability perspective by considering all
three bottom lines. What triple bottom line
advocates can gain from the analysis presented here is a methodology for calculating
their bottom lines. This would allow them to
respond to their critics, who contend that construction of such bottom lines is neither feasible nor possible.18
Economic Value Added (EVA) is wellknown and widely adopted in business, and
contends that an action creates economic
value when a company’s operating profit from
the activity exceeds the opportunity cost of
all capital invested in the enterprise. This essentially means that any returns should exceed the other best use of the shareholder’s
funds.
EVA = net operating profit after taxes (capital × cost of capital).
Noneconomic parameters are less defined,
and this is the key growth point that is needed in the field of CSP measurement. What is
clear from Hughes and colleagues’ model is
that the noneconomic parameters refer to
value added to the noncommercial sectors of
society; these are described as social/professional and public/political.
GLOBAL VALUE ADDED MEETS THE
BUSINESS CONTEXT
The purpose of this research is to construct
a measurement methodology to evaluate the
value created or destroyed by individual cor-
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porate social responsibility projects. The metric that is created must both be relevant to the
business community and inclusive of social
concerns. We therefore suggest the decomposition of GVA into two slightly different primary components: CVA (Corporate Value
Added) and NCVA (Noncorporate Value
Added). CVA represents all value that accrues
to the corporation, while NCVA represents all
value that accrues to parties that are not directly associated with the corporation itself.
This would exclude corporate employees, but
include community members who are not employees. We further depict the relationship
between CVA and NCVA as a function (f ), as
opposed to a linear additive model, to allow
for the modeling of nonlinear relationships between the variables. While the nature of the
function will be determined in future work
(and is beyond the scope of this article), we
anticipate that the relationship between the
two variables will sometimes, if not always,
be nonlinear.
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firms in the commercial sector) for practical
purposes of measurement does not alone constitute an acceptance of the Separation Thesis. It should be noted that we specifically use
the term CVA instead of EVA because, in addition to monetary benefits, there is the potential for nonmonetary value to accrue to
corporations that engage in CSR projects. In a
sense, we have combined business and social
concerns into one component, CVA, thus rejecting the Separation Thesis.
An example of a nonmonetary benefit
would be the positive gains in employee morale due to a company’s commitment to corporate social responsibility. While management specialists have shown how CSR commitments can lead to competitive advantages
in the marketplace in hiring and retaining
employees,20 we argue that there is a value to
such nonmonetary goods that does not wholly
reduce to dollar terms, at least initially. Thus,
CVA can be thought of in the following way:
CVA = f (EVA, Nonmonetary Value Added)

GVA = f (CVA, NCVA)
In using CVA and NCVA as the main components of GVA, we accept that a key distinction for corporate decision makers is between
the corporation and society, and so, for the
purpose of analysis, the two terms are considered mutually exclusive. We believe that
this separation will be useful to corporate decision makers because it is easier to think of
the firm as the unit of analysis as opposed to
the entire commercial sector, which potentially includes competing firms. Despite this
separation, it should be noted that aspects of
CSR projects may simultaneously contribute
value to both CVA and NCVA.
Some may object that we have committed
to the Separation Thesis that Freeman in particular decries.19 This thesis proposes that the
realms or discourses of business and ethics
are separate and should not or cannot be considered jointly. Separating the decision maker
from the rest of the world (including other

NCVA is an umbrella term that includes
monetary and nonmonetary value added or
destroyed in the social-professional or political sectors. It excludes any monetary or nonmonetary value added or destroyed for the
firm in question, but includes effects on the
commercial sector, excluding the firm. NCVA
allows us to consider domains that involve
all sectors of society and thus may be difficult to map on to only one of the sectors. In
sum, NCVA can be represented in the following way:
NCVA = f (Monetary Value Added to Society,
Nonmonetary Value Added to Society)
A potential objection to our formulation
of the GVA equation could be that it ignores
the CSR-type activities that are taken on by
the political/public sector using the tax dollars extracted from the commercial sector, or,
alternatively, that it ignores the CSR-type ac-
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tivities that the social/professional sector engages in using the charitable donations provided by the commercial sector. This is a valid
point, but it merely demonstrates the need to
extend the research that the authors present
in this article. The multi-sector model is valuable precisely because all sectors contribute
to the domains contained in NCVA, and expansion of this measurement methodology to
include other sectors is desired and needed.
For instance, this methodology could, by measuring GVA for activities in the noncommercial sectors, provide a measure for use in
evaluating, say, tax policies enacted by the
government or programs run by NGOs. However, we begin by demonstrating that such a
measurement methodology is valid for firms
in the commercial sector.

MEASURING UNITS

MEASURING CVA AND NCVA
As noted, CVA and NCVA have monetary
and nonmonetary components. A central challenge of this article is to examine the validity
of making these monetary and nonmonetary
components commensurate within CVA and
NCVA. If this can be done, we must demonstrate that CVA and NCVA can themselves be
made commensurate to create a standard GVA
unit. Thus, what follows is a discussion of
units, domains, and measurement scales. This
is a prerequisite to the application of a measurement methodology establishing whether
creation of a standard GVA unit is conceptually and methodologically feasible. If this is
successfully established, much work that falls
beyond the scope of the present research will
remain. To create valid measurement scales
will require the work of many and will warrant the emergence of a subdiscipline in business and economics. To use these scales in
suitable ways will be a challenge on yet another level. The final section of the present
article will offer only preliminary thoughts
about how such measures could be used and
misused.
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The monetary portions of CVA and NCVA
already have a standard unit in the various
currency units of different countries. One currency unit can be easily translated into foreign currencies using a conversion index, and
doing so is standard practice. The monetary
domain of CVA or EVA derives from the management literature, and the methods for calculating it are well developed. The monetary
domain of NCVA is represented by monetary
gains (or losses) to society, and the indicators
used to measure it come from the field of
macroeconomics. There is little theoretical
difficulty here; the unit is already standardized, the domains of interest are well discussed, and transaction and accounting practices to arrive at an objective dollar value are,
generally speaking, established.
COMMODIFICATION
In contrast to the monetary components
of CVA and NCVA, the nonmonetary components do not have a standard unit. In addition, these nonmonetary components must be
made commensurate with the monetary components in both the CVA and NCVA terms
before these terms can be made commensurate with each other. Before continuing, we
must discuss the philosophical implications
of this process. Some might object that making nonmonetary elements commensurate
with elements that carry a dollar value is acting against the ethical basis for CSR by
commodifying these nonmonetary elements.
However, we argue that this is not the intention, and making monetary and nonmonetary
elements commensurate is actually necessary
for decision making to take account of social
concerns.
The final units that will be used to measure CVA, NCVA, and GVA could be expressed
in multiple ways. They will be units of GVA
that combine monetary and nonmonetary
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value. In theory, a conversion index could be
created to reduce these units to monetary
value, or monetary value could be converted
to nonmonetary units. While methodologically possible, whether, how, and when this
is appropriate will depend on the analysis and
use in question. In all cases, when such conversion occurs, it must be explicitly recognized so that the limits to its resulting meaning can be understood.
We see the measurement of GVA as a tool
to inform business decision making in an
analogous way that quality-adjusted life year
(QALY) analysis is a tool that informs health
decision making in the public realm.21 QALY
analysis involves combining measurements of
the quality of life (a nonmonetary element)
with the quantity of life gained or lost from
using certain medical procedures, devices, or
drugs. This number, in turn, is multiplied by
economic value in dollar terms of one year of
perfectly healthy life—the value of which is
open to considerable debate. The benefits of
a given medical procedure would then be
compared to the price in dollar terms of the
medical procedure being evaluated, and a decision would flow from that comparison. The
intention of this line of research is not to
commodify quality of life, but to provide a
metric by which to measure certain nonmonetary phenomena to inform decision making
on important matters of public health. We seek
to do the same for firms in the commercial
sector to make sure that the decisions made
in this sector are informed by concerns of social responsibility.
DOMAINS AND SCALES
In order to define the nonmonetary components of CVA and NCVA, we turn primarily to the corporate social responsibility literature, which has laid out a number of relevant domains. For example, Global Sullivan
Principles of Social Responsibility presents
eight domains of interest:

•
•
•
•
•
•
•
•

human rights,
equal opportunity and lack of exploitation,
respect for freedom of association,
fair compensation of employees,
health and environmental sensitivity,
respect for intellectual and property rights,
improving the quality of life of communities in which businesses operate, and
promotion of the aforementioned principles.

Domini Social Investments presents six
“screens” for investment opportunities:
• corporate citizenship,
• diversity,
• employee relations,
• environment,
• sensitivity in non-U.S. operations, and
• production of safe and useful products.
While the organizations that establish
these domains do define them to some degree,
the content areas that are contained within
them are often still broad and perhaps purposefully vague. These content areas of interest remain to be fleshed out, and they will be
at least partially dependent on the CSR project
being evaluated. However, if domains are
specified on a project-by-project basis, these
will need to be established using accepted
methods. In the social sciences, the usual
method is to conduct focus groups with all
identifiable, relevant stakeholders to elicit
domains of relevance from the perspective of
participants. Mitchell, Agle, and Wood have
created a framework for the identification of
relevant stakeholders.22 The results of these
discussions are then analyzed using content
analysis. Once a survey has been constructed,
it is possible to conduct exploratory factor
analysis and confirmatory factor analysis on
the response data, to identify empirically
which domains appear to be independent
entities and which are actually the same as
another domain or which need more survey
items to be sure. Factor analysis can also iden-
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tify areas within a domain. Areas may have
their own measurement scales. Domains may
be assessed by deriving a composite score from
all the constituent areas’ scaled measurements.
The nonmonetary domains of CVA deal
primarily with employee relations and reputation, and thus scales to measure these phenomena would most likely be found in the
industrial relations and management literature. The nonmonetary portions of NCVA deal
with a wider variety of social and political
phenomena, such as health, environment, social capital, and income inequality. Thus,
measures will derive from community quality of life studies, macroeconomics, political
science, and sociology. We present several
sample domains in table 1, which are derived
from the literature in the aforementioned
fields. In many cases, scales for certain CSR
domains have not yet been constructed or validated. This creates the need for businesses and
researchers to fill the gap by constructing and
validating scales for the identified areas.
The end goal for what will need to be an
emerging field of measurement in business
and economics is the production of a body of
valid measures that largely cover the measurement needs of all nonmonetary areas within
domains in the CVA and NCVA categories. In
order for the public to be confident that these
are valid measures, a clearinghouse of measures that have known validation parameters
will eventually be necessary. With such a reTable 1
Sample Domains for Analysis
Monetary
CVA
NCVA

EVA (Economic Value
Added)
Tax revenues,
private income

Nonmonetary
Employee relations,
reputation
Health, environment,
social capital,
income inequality
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source, an industrial index for GVA could require, for instance, that each CSR project’s
domains be measured by scales from the clearinghouse that meet identified rigorous standards.
SUMMARY OR
LATENT TRAIT SCALES
GVA is, by definition, comprised of domains that differ and of areas within each
domain that differ. The scales by which each
area is measured, even if the units by which
the scales are measured are the same, may not
be combined without appropriate attention to
how it is done. Item response theory (IRT)
provides a well-tested methodology for this
problem that has been used extensively in
other fields. IRT has been routinely applied
in educational testing to measure ability or
proficiency (for example, the Graduate Management Admission Test—GMAT—score) and
psychological assessment to measure personality traits (for example, extroversion). IRT has
recently gained wide acceptance and has been
applied to assess multidimensional healthrelated quality of life, due to the observation
that it provides more adaptable and effective
methods to construct measurement instruments, to conduct analysis, and to assign
scores that complement those derived from
classical test theory. However, its use in business settings is still in its infancy. A major
appeal of IRT is that it provides an integrated
psychometric framework for developing and
scoring tests or questionnaires. The key feature of relevance here is that IRT involves
positing an underlying or latent trait that encompasses the scales from all relevant areas,
and that can itself form an anchor scale. We
propose that IRT can be used for commercial
activities, not only because it is an excellent
method for measurement, but also because the
latent trait in our case could be GVA. IRT can
provide the method by which a summary
score for GVA, comprised of appropriately
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chosen and arrayed measures from the full
range of relevant areas in the domains of interest, can be generated.
USING ITEM RESPONSE THEORY
TO BUILD A LATENT TRAIT
MODEL FOR GVA
IRT is a statistical theory consisting of
mathematical models expressing the probability of endorsing a particular response to a test
or survey item as a function of the ability or
latent trait of the person, and of certain characteristics of the item.23 IRT posits an underlying, unobserved trait on which the items are
hierarchically arrayed (located) on the trait
continuum, which extends from easiest (most
likely to be endorsed) to most difficult (least
likely to be endorsed). Domains of interest in
the GVA application, each with relevant
scales, can be placed on a to-be-defined GVA
line. In a similar way, persons can be measured in terms of their achievement and calibrated onto a common metric (see figure 1).
In the case of commercial activity, it would

be projects or companies rather than persons
that could be arrayed.
To distinguish IRT scores from their classical test theory counterparts, “scale” scores
are commonly used. The main advantages of
scale scores are that they: (1) remain comparable when items (questions) are added to or
deleted from the tests; (2) weight the individual items optimally according to their discriminating powers (information contribution); (3) have more accurate standard errors;
(4) provide more flexible and robust adjustment for guessing or estimating than classical
correlations; and (5) are on the same continuum as the item locations. Once an underlying scale for GVA has been constructed and
available scales or items are arrayed along it,
gaps or areas that remain in need of measurement are readily identified and additional
items to fill the gaps can be constructed. The
provision of IRT for treating the items, or small
sets of similar items, as the exchangeable units
of test construction and scoring has led to numerous innovations in test practice, including test development and refinement, test

Figure 1. Arraying Measured Entities and Measurement Parameters on a Latent Trait

Project or Corporation
C

C
P

P

C

P

C
P

C
C
C

P

P
P

P

C
C

C

P

P

W

X

X

I

X

S

X

X

I

X

S

S

I
X

X

I

X

S

Items/Scales
C = corporation; GVA = Global Value Added; P = project; I = item or question; S = measurement scale

Latent trait
(GVA)

Volume 1, Number 2

Organizational Ethics

equating, test scaling, differential item functioning, item banking, and adaptive testing.
We propose that the use of IRT models will
enable the development of more targeted survey items to construct accurate and efficient
scales for areas within domains and to array
scales as components along an underlying
GVA construct or measure.
MANAGEMENT
DECISION MAKING
Once a GVA score is attainable for specific
projects, we see a place for GVA scores in
management decision making. In particular,
we hope to enable corporate decision makers
to estimate projected GVA, including its CVA
and NCVA components, of every commercial
enterprise and CSR project. With regard to CSR
projects, each will need to be evaluated. The
relevant corporate social responsibility domains and content areas will be identified
using the focus group methods noted above.
Validated scales measuring these content areas will be extracted from the appropriate lit-

eratures. If scales do not exist, then they will
be constructed and validated. IRT methodology will be applied to make commensurate
the monetary and nonmonetary elements to
create CVA and NCVA anchor scales.
This allows projects to be plotted in one
of the four quadrants of figure 2, below, to reflect how CSR projects contribute or destroy
value for the corporate and noncorporate sectors. Only projects in Quadrant I offer sustainable investment. In general, the further to the
right, the greater the CSP, and the further up,
the better the CFP. However, there is not a oneto-one correspondence between CVA and CFP
or between NCVA and CSP. This is because
the social performance that relates to the corporation (for example, employee relations) is
included in the CVA term, and thus NCVA is
not a complete measurement of CSP. Projects
starting in Quadrant IV may become sustainable investments after start-up costs have begun to pay dividends.
The establishment of this measurement
methodology implies that strategic management teams would benefit from the contribu-

Figure 2. Mapping GVA
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III
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IV

Social benefit without economic return;
projects may start in this quadrant;
unsustainable in long term if project does
not move Quadrant I.
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tions of a methodologists’ predictive modeling based on estimated GVA measures.
TIME DIMENSION AND
MEASUREMENT INTERVALS
A further dimension needs to be added to
this decision analysis, and that is time. As
noted above, a CSR project may begin in Quadrant IV, having a positive NCVA and negative
CVA, but over time shift to Quadrant I and
become a sustainable investment. As shown
in figure 3, there are two possible outcomes
for Year 2 (a and b). While both are in Quadrant I, they vary in their proportions of CVA
and NCVA. Whether one outcome is superior
to other, since both are sustainable, will depend on the goal of the project.
It will be up to business decision makers
to determine the time frames for their CSR
projects. Firms will be able to plan for the future of their CSR projects by determining the
function of the line between the starting point
of their CSR project and their ideal future
point in Quadrant I. It also provides a method
of evaluating the success or failure of said
projects by how closely they adhere to this
line’s equation. For instance, it is possible that
CSR projects require a longer time horizon
than traditional business projects, as societal
effects may not be manifest for many years,
and the set-up period of certain projects may
be longer due to international law or a specific country’s legal requirements.

A major potential use of GVA measures
will be the creation of industrial indices analogous to the Dow Jones index or NASDAQ,
which purport to measure the economic success of firms, but incorporating nonmonetary
value to stakeholders. In fact, we see the creation of multiple indexes, which may each
focus on a particular NCVA domain, such as
environmental protection, or a GVA index that
will include only businesses from one industry. An NCVA index that includes all firms
could represent the comparative success of
businesses in pursuing socially responsible
business practices, akin to the Domini 400
Social Index that was critiqued in the first
section of this article. This could be a companion to the Dow Jones index. A comprehensive GVA index could subsume Dow Jones
considerations under its umbrella and would
offer a comprehensive picture of the business
and its interaction with society.
While these indexes have the potential to
impact positively on how business actions
should be judged, they can also be misused
in a variety of ways. As with any measurement device, the numbers used to create an

Figure 3. Progess of Projects’ GVA Over Time
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index or score can be manipulated to present
a firm’s business actions in a more positive
light. This could be done by focusing on one
domain of NCVA for which a firm performs
very well while ignoring another domain in
which it is destroying societal value. There
will also be various ways to evaluate a CSR
project on the time dimension. One could
measure the absolute value added, the change
in value added, or the cumulative value added
over a certain period of time. A given CSR
project may look more or less successful based
on which of these evaluations one pursues.
Businesses and watchdog groups will be
free to create their own indexes for internal
use or publicity purposes. We encourage the
erection of safeguards to ensure that the methodology behind these indexes is sound, including the creation of a body of valid instruments for measurement as described above.
Related to this is the need to establish a fair
method for including or excluding companies
from the “public” indexes, such as the GVA
index that would serve as a comprehensive
Dow Jones. Questions of whether criteria
should be more or less stringent for companies in certain sectors or operating in developing countries are relevant and important as
well. Whether this is done through government regulation, self-policing, or some other
method is a normative question that goes beyond the scope of this article.
GVA may also potentially be used by governments to modify tax laws and other regulatory laws. For instance, a governing body
could provide special tax breaks to companies that engage in successful GVA projects,
and nonprofit organizations could be required
to perform by GVA standards in order to retain their tax-exempt status. There is great
potential to stimulate strong social responsibility activity and to combine economic productivity with CSP. However, there is also
great potential to apply regulations that tip
the balance between CSP and traditional economic performance in unfavorable ways or
that emphasize some types of social projects
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over others that may ultimately be more controlling than is good for society. These subjects are important but fall beyond the scope
of the present article.
AN EXAMPLE
To illustrate how such measures could be
used, consider a collaborative CSR project
such as the African Comprehensive HIV/AIDS
Partnerships (ACHAP).24 This was a true partnership between the three sectors of society:
international pharmaceutical companies, including Merck, in the commercial sector; several foundations and medical professional
groups from the United States and NGOs in
Botswana in the social-professional sector;
and the government of Botswana in the political sector. Antiretroviral and other drugs
were distributed and care was provided to
HIV/AIDS patients along with public education efforts to the people of Botswana. Measures for the GVA of the project taken at the
outset could show a strong positive NCVA and
a negative CVA that is offset only by the reputation for selfless professionalism by Merck.
However, a longer-term analysis may show a
positive CVA due to the market development
that happens as a result of ACHAP. Which
measures and over what time periods they
should be used and how accountability should
be rendered for performance on GVA components are all matters that will come up for scrutiny once the practice of measuring GVA components has become commonplace.
For Merck to assess the GVA of ACHAP, it
might take the following steps. First it would
consider which aspects of the project benefit
Merck, that is, fall into the CVA category. It
might consider market development in the
monetary subcategory of CVA. It might consider improved reputation in monetary benefits due to enhanced sales based on quality
reputation, and in less tangible features such
as employee pride that would fall into the
nonmonetary subcategory of CVA. Second,
Merck would consider what types of NCVA

92

Fall 2004

Organizational Ethics

might exist, whether monetary or nonmonetary. In the Botswana Comprehensive HIV/
AIDS Project (BCHAP) project, for instance,
they would be interested in the impact of their
preventive health education, in the change in
HIV/AIDS related morbidity and mortality, in
the indirect benefits of improvement in either
one, such as improved mental health, social
norms and networks, and economic productivity in the form of tax revenues. To ensure a
suitably comprehensive measure of GVA, all
the domains within both CVA and NCVA
would be captured using focus group discussions, with focus groups being drawn from
among all the stakeholders in the issue under
consideration. These groups might include
citizens with HIV in Botswana, family members, employees, government officials, and
others. Using trigger questions, facilitators
would lead a discussion about what matters
have importance to the stakeholders; content
analysis of these focus groups would then result in a list of domains.
These domains would then be used to either identify or create valid measures for the
areas within that domain. So, for instance, if
the focus group identifies that it is important
to have a supportive culture for HIV-positive
people, a survey-based scale would be sought
that would estimate how supportive the culture is at the outset and then after the project
gets underway.
For a full evaluation of the GVA of this or
any other project, numerous methodological
issues would need to be taken into account,
and an ideal study design may not possible in
the real world of practicalities. However, the
measurement sciences can produce estimates
far better than tend to exist currently, even
within the constraints of the real world of
practicalities.
NEXT STEPS
We hope that we have laid the foundation
for the creation of one or a series of anchor

scales to measure the impact of corporate social responsibility projects, taking into account social and economic concerns. However, many important steps remain, and many
of them are further specifications of the sections we have discussed in this article. First,
domains, content areas, and measurement
scales need to be further specified so that we
know the gaps that exist in measurement of
crucial societal and business phenomena.
Those gaps need to be addressed through the
construction and validation of new scales.
Then the steps that are necessary to apply
IRT and related methodologies to create a variety of anchor scales, such as a GVA anchor
scale, need to be described and performed.
This raises the question of what the criteria
will be for selecting businesses to be in the
more comprehensive public indexes; they
could be limited in the number of companies
they describe, as is the case with the Dow
Jones, or the type of activity as with the
NASDAQ. Finally, the indexes need to be
empirically validated with a variety of CSR
projects, and later, with all corporate actions
and activities. While we have established the
methodological validity of our method, it remains to be seen if the results will intuitively
ring as true when applied to a series of case
studies.
CONCLUSION
Social productivity is an obligation of corporations according to stakeholder theory. To
promote the apportionment of credit where
credit is due and to promote the improvement
of CSP, including its balance with economic
productivity, we have sought to set out a
method for identifying the full set of domains
in which social productivity can exist and for
measuring social productivity. If this proposed
methodology is accepted, much still remains
to be done to create measures and to implement measurement procedures. Widespread
measurement will allow creation of indexes
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for GVA that will permit a new and potentially more balanced way of assessing and
holding accountable the commercial sector of
society. The systems for such accountability
will require intense attention to ensure that
they yield a net improvement to society as a
whole.
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